About Careers Internship MedBlog Contact us

Breakthrough in Treating Irreversible Liver Cirrhosis

by Hannah Punitha on August 24, 2008 at 3:47 PM
 Breakthrough in Treating Irreversible Liver Cirrhosis

Researchers at Cold Spring Harbor Laboratory (CSHL) have found that a stable form of cell-cycle arrest, known to offer potent protection against cancer, also limits liver fibrosis - a condition characterized by an excess of fibrous tissue.

Liver fibrosis, triggered by chronic liver damage produced by hepatitis infection, alcohol abuse, or fatty liver disease, can lead to cirrhosis, a major health problem worldwide.


According to researchers, the new findings may have important implications for treating cirrhosis, a disease now considered to be irreversible. It could offer new insight into other disease states as well.

"Fibrosis is a disease of many organs-lungs, kidneys, pancreas, prostate, skin. It's possible this mechanism in the liver is relevant to fibrotic situations in other tissues," said Valery Krizhanovsky of Cold Spring Harbor Laboratory.

Krizhanovsky said that the state of cell-cycle arrest known as senescence was first described decades ago, but the phenomenon was thought to occur only in cultured cells in the laboratory.

More recent studies found that cellular senescence helps protect against the formation of tumors and aids in the response to certain anticancer agents.

To study the potential role of senescence in liver cirrhosis, the researchers examined mice treated with a liver-damaging agent.

They found that senescent cells accumulated in the livers of the mice, derived primarily from activated stellate cells.

Stellate cells are those that initially proliferate in response to liver damage and are responsible for producing the extracellular matrix, a kind of structural support for cells that is the hallmark of fibrotic scars.

"Once a lot of extracellular matrix has formed, it's very hard to clear. The material just sits there and creates an inflammatory environment," Krizhanovsky said.

However, their new findings offer some hope. The senescent stellate cells showed signs of reduced secretion of extracellular matrix components, enhanced secretion of enzymes that degrade extracellular matrix, and enhanced immune surveillance.

They found that accordingly natural killer cells preferentially target senescent-activated stellate cells both in cell culture and in living animals, helping to resolve fibrosis.

On contrary, stellate cells continued to divide in mice lacking key components of the senescence program, leading to excessive liver fibrosis.

The results suggest that immunostimulatory therapies might enhance senescent cell clearance and should be tested for the potential treatment of patients with liver fibrosis, especially in its early stages or following short-term exposure to liver toxins.

The study is published in the August 22nd Cell, a Cell Press publication.

Source: ANI
Font : A-A+



Recommended Readings

Latest Research News

Brain Circuits That Shape Bedtime Rituals in Mice
New study sheds light on the intrinsic, yet often overlooked, role of sleep preparation as a hardwired survival strategy.
NELL-1 Protein Aids to Reduce Bone Loss in Astronauts
Microgravity-induced bone loss in space, can be reduced by systemic delivery of NELL-1, a protein required for bone growth and its maintenance.
Connecting Genetic Variants to the Alzheimer's Puzzle
Researchers establish connections between Alzheimer's-linked genetic alterations and the functioning of brain cells.
Gene Therapy Sparks Spinal Cord Regeneration
Team at NeuroRestore introduces a groundbreaking gene therapy that has effectively promoted nerve regrowth and reconnection, post spinal cord injury.
Unlocking the Gut Microbiome's Influence on Bone Density
Scientists aim to pinpoint particular functional pathways affected by these bacteria that may have an impact on skeletal health.
View All
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close
Greetings! How can I assist you?MediBot

Breakthrough in Treating Irreversible Liver Cirrhosis Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests